The prospective study of focal high-dose rate brachytherapy for primary clinically localized prostate cancer
Not Applicable
- Conditions
- Prostate cancer
- Registration Number
- JPRN-UMIN000040121
- Lead Sponsor
- Kawasaki Medical School Hospita, Department of Urology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Male
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
1.Prostate cancer region close to rectal wall 2.multiple cancer region diagnosed by prostate biopsy 3.Medical history for radiation therapy of the pelvis 4.Unfit for regularly MRI examination for follow-up 5.Administration of glucocorticoid or 5-arufa reductase 6.Actively double cancer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.The safety for focal high-dose rate brachytherapy using Irisium for clinically localized prostate cancer 2.The efficacy for pathological evaluation of re-biopsy of focal radiation region
- Secondary Outcome Measures
Name Time Method